About Joshika Pharma
Joshika Pharma is a Healthcare company based in Hyderabad (India) founded in 2016. It develops innovative technologies for specialized pharmaceutical formulations. It operates on a B2B model. Its Indian entity Joshika Pharma Private Limited reported revenue of ₹8.35 Cr. Its focus areas include Pharmaceuticals, Drug Development and Niche Formulations. Its competitors include Unither, Akums, Jubilant Life Sciences, Recipharm and CoreRx and 3 more; 4 of its 8 listed competitors have raised funding.
Company details
Joshika Pharma operates with a B2B model, focusing on providing healthcare solutions, producing pharmaceutical products, drug development, and niche formulations. Develops innovative technologies for specialized pharmaceutical formulations. It emphasizes efficiency, client-focused solutions, and growth, fostering partnerships and innovation in its operations.
- Headquarters Hyderabad, India
- SectorsHealthcare
- Website joshikapharma.in
- Legal Name Joshika Pharma Private Limited
- Date of Incorporation 19 Nov, 2012
- Jurisdiction Hyderabad, Telangana, India
- Annual Revenue₹8.35 Cr
FY 2023 · -56% YoY
- Net Profit₹3.3 Lakh
FY 2023 · 0% margin
- EBITDA₹45.5 Lakh
FY 2023 · 5% margin
Associated legal entities of Joshika Pharma
Joshika Pharma operates through Joshika Pharma Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2023) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Joshika Pharma Private Limited CIN U24100TG2012PTC084224 | Active | 19 Nov 2012 | Hyderabad, Telangana | ₹8.4 Cr | – | 2 | View details |
Board of directors of Joshika Pharma Private Limited (Joshika Pharma)
Joshika Pharma Private Limited is the primary company behind Joshika Pharma. The board of Joshika Pharma Private Limited currently have 2 directors; the longest-serving is Usha Devalla, appointed in 2016. 8 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Usha Devalla DIN 07511156 | Director | 25 May 2016 | 10 yrs 4 mo | Joshika Pharma Private Limited |
| Gamidi Rao Srinivasa DIN 07511161 | Director | 25 May 2016 | 10 yrs 4 mo | Joshika Pharma Private Limited |
Financials of Joshika Pharma
Figures of Joshika Pharma Private Limited, the primary company behind Joshika Pharma, for FY 2023. Revenue was ₹8.35 Cr (-56% year on year). Net profit was ₹3.3 Lakh (0% margin). EBITDA was ₹45.5 Lakh (5% margin). Revenue has grown at a compounded annual rate of -6% over three years and +22% over five years.
- ₹8.35 CrRevenue · FY 2023 · -56% YoY
- ₹3.3 LakhNet profit · 0% margin
- ₹45.5 LakhEBITDA · 5% margin
- ₹40 LakhPaid-up capital
- -6%Revenue CAGR, 3 years
- +22%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Joshika Pharma Private Limited are on its company page.
Detailed financial statements for Joshika Pharma
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Competitors of Joshika Pharma
Joshika Pharma has 8 listed competitors in our database, 4 of them funded. They include Unither, Akums, Jubilant Life Sciences, Recipharm and CoreRx, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| unither-pharma.com | 1993 | Paris, France | – | – | Contract development and manufacturing organization for proprietary and generic drugs | |
| akums.in | 2004 | Delhi, India | $70M | 395 | CDMO focusing on spectrum of dosage forms and therapeutic segments | |
| jubl.com | 1978 | Noida, India | – | – | Company offering a suite of R&D and manufacturing services for small molecules and generics | |
| recipharm.com | 1995 | Jordbro, Sweden | – | 1,083 | Pharmaceutical development and manufacturing services are offered contractually. | |
| corerxpharma.com | 2006 | Clearwater, United States | $15M | – | CDMO with a focus on early phase drug product development | |
| neclife.com | 1995 | Chandigarh, India | $46.85M | 175 | Cephalosporin APIs and generic formulations are manufactured. | |
| windlas.com | 2001 | Gurugram, India | $12.96M | 1,264 | Biopharma regulatory affairs, quality control, and strategy services are provided. | |
| medpharm.com | 1998 | Guildford, United Kingdom | – | 108 | Topical and inhaled drug delivery formulations are developed and manufactured. |
Detailed competitors of Joshika Pharma
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Pharmaceuticals & Distribution
10 companies that operate in the same segment as Joshika Pharma (Pharmaceuticals & Distribution), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Pharmaceutical products are manufactured and marketed worldwide. | 1891 | Kenilworth, Warwickshire, United Kingdom | – | USD 64.93 B | 781 | |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. | 2014 | New York, New York, United States | USD 1.3 B | USD 8.26 M | 750 | |
Developer of pharmaceutical products for treating multiple diseases | 1980 | Thousand Oaks, California, United States | – | USD 33.23 B | 28,000 | |
Biopharmaceutical research and drug development are conducted globally by AbbVie. | 2012 | Chicago, Illinois, United States | – | USD 61.16 B | 55,000 | |
Traditional pharmaceutical medicines are developed for multiple health fields. | 1876 | United States | – | USD 65.18 B | 47,000 | |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others | 1987 | Foster City, California, United States | – | USD 29.45 B | 17,600 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology. | 1993 | San Francisco, California, United States | USD 215.5 M | USD 29.62 M | 225 | |
Developer of medical devices, generic pharmaceuticals, and nutrition products | 1888 | Libertyville, Illinois, United States | – | USD 44.33 B | 3,710 | |
Medicines and health products are retailed through pharmacy outlets. | 2006 | Hyderabad, Telangana, India | USD 268.78 M | USD 734.57 M | 25,010 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Joshika Pharma
Joshika Pharma was founded in 2016.
Joshika Pharma is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
The primary company behind Joshika Pharma, Joshika Pharma Private Limited, reported revenue of ₹8.35 Cr for FY 2023, down 56% year on year.
Joshika Pharma operates with a B2B model, focusing on providing healthcare solutions, producing pharmaceutical products, drug development, and niche formulations. Develops innovative technologies for specialized pharmaceutical formulations. It emphasizes efficiency, client-focused solutions, and growth, fostering partnerships and innovation in its operations.
Joshika Pharma's top competitors include Jubilant Life Sciences, Akums and Nectar Lifesciences.
Joshika Pharma operates through Joshika Pharma Private Limited.
The legal entities of Joshika Pharma currently have 2 directors, including Usha Devalla, Gamidi Rao Srinivasa.